{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T10:13:44Z","timestamp":1792059224701,"version":"4.4.0"},"reference-count":37,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2022,1,3]],"date-time":"2022-01-03T00:00:00Z","timestamp":1641168000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005925","name":"Buddhist Tzu Chi Medical Foundation","doi-asserted-by":"publisher","award":["TCMMP109-02-01"],"award-info":[{"award-number":["TCMMP109-02-01"]}],"id":[{"id":"10.13039\/501100005925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Toxins"],"abstract":"<jats:p>This study investigated the satisfaction with continued detrusor Botox injections for urinary incontinence and conversion to other surgical procedures and bladder management procedures for neurogenic detrusor overactivity (NDO) in patients with chronic spinal cord injury (SCI). A total of 223 patients with chronic SCI underwent detrusor Botox 200U for urodynamically confirmed NDO and urinary incontinence. After initial detrusor Botox injections, patients opted to either continue detrusor Botox injections every six to nine months and on clean intermittent catheterization (CIC), switch to other bladder management procedures, or receive surgical procedures to improve their urinary incontinence, correct emergent complications, or have better voiding conditions without CIC. Urinary incontinence improvement rates and satisfaction with bladder management were assessed and compared between different subgroups, urodynamic parameters, and bladder management procedures. Finally, a total of 154 male and 69 female patients were included, among whom 56 (25.1%), 81 (36.3%), 51 (22.9%), and 35 (15.7%) showed a marked, moderate, mild, and no reduction in urinary incontinence, respectively. However, only 48.4% of the patients continued detrusor Botox injections over the mean follow-up period of seven years. Patients with cervical or thoracic SCI had fair incontinence improvement rates. The presence of high detrusor pressure and higher-grade bladder outlet resistance also predicted a decrease in incontinence. Although more than 50% of the patients switched to other bladder management procedures or received surgical treatment, 69.1% expressed satisfaction with their current status. This large cohort of patients with chronic SCI who received initial detrusor Botox injections revealed that only 48.4% continued with Botox injections. Those who received surgical procedures due to urological complications or demanded change in bladder management could achieve high satisfaction rates.<\/jats:p>","DOI":"10.3390\/toxins14010035","type":"journal-article","created":{"date-parts":[[2022,1,9]],"date-time":"2022-01-09T23:35:09Z","timestamp":1641771309000},"page":"35","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Satisfaction with Detrusor OnabotulinumtoxinA Injections and Conversion to Other Bladder Management in Patients with Chronic Spinal Cord Injury"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1761-1185","authenticated-orcid":false,"given":"Sheng-Fu","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Urology, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Tzu Chi University, Hualien 97004, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-Hong","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Urology, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Tzu Chi University, Hualien 97004, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Fong","family":"Jhang","sequence":"additional","affiliation":[{"name":"Department of Urology, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Tzu Chi University, Hualien 97004, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7165-4771","authenticated-orcid":false,"given":"Hann-Chorng","family":"Kuo","sequence":"additional","affiliation":[{"name":"Department of Urology, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Tzu Chi University, Hualien 97004, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,1,3]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/S0090-4295(99)00553-1","article-title":"Association of level of injury and bladder behavior in patients with post-traumatic spinal cord injury","volume":"55","author":"Weld","year":"2000","journal-title":"Urology"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.tcmj.2014.07.004","article-title":"Clinical guidelines for the diagnosis and management of neurogenic lower urinary tract dysfunction","volume":"26","author":"Kuo","year":"2014","journal-title":"Tzu Chi Med. J."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/nau.22445","article-title":"Targets for botulinum toxin in the lower urinary tract","volume":"33","author":"Cruz","year":"2014","journal-title":"Neurourol. Urodyn."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/nau.21246","article-title":"Mechanisms of action of botulinum neurotoxins, \u03b23-adrenergic receptor agonists, and PDE5 inhibitors in modulating detrusor function in overactive bladders: ICI-RS 2011","volume":"31","author":"Kanai","year":"2012","journal-title":"Neurourol. Urodyn."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.urology.2012.12.021","article-title":"Botulinum Toxin A Detrusor Injections Reduce Postsynaptic Muscular M2, M3, P2X2, and P2X3 Receptors in Children and Adolescents Who Have Neurogenic Detrusor Overactivity: A Single-blind Study","volume":"81","author":"Priefert","year":"2013","journal-title":"Urology"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.neuint.2005.04.021","article-title":"Enhanced ATP release from rat bladder urothelium during chronic bladder inflammation: Effect of botulinum toxin A","volume":"47","author":"Smith","year":"2005","journal-title":"Neurochem. Int."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.neuint.2007.11.006","article-title":"Botulinum toxin type A normalizes alterations in urothelial ATP and NO release induced by chronic spinal cord injury","volume":"52","author":"Smith","year":"2008","journal-title":"Neurochem. Int."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1046\/j.1464-410x.2001.02190.x","article-title":"Capsaicin receptor VR1 and ATP-gated ion channel P2X3 in human urinary bladder","volume":"87","author":"Yiangou","year":"2001","journal-title":"BJU Int."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1016\/j.juro.2011.02.004","article-title":"Efficacy of botulinum toxin a injection for neurogenic detrusor overactivity and urinary incontinence: A randomized, double-blind trial","volume":"185","author":"Herschorn","year":"2011","journal-title":"J. Urol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.eururo.2011.07.002","article-title":"Efficacy and safety of onabotulinumtoxina in patients with urinary incontinence due to neurogenic detrusor overactivity: A randomised, double-blind, placebo-controlled trial","volume":"60","author":"Cruz","year":"2011","journal-title":"Eur. Urol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1016\/j.juro.2012.01.125","article-title":"Phase 3 efficacy and tolerability study of onabotulinumtoxina for urinary incontinence from neurogenic detrusor overactivity","volume":"187","author":"Ginsberg","year":"2012","journal-title":"J. Urol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.juro.2016.04.046","article-title":"Long-Term efficacy and safety of onabotulinumtoxina in patients with neurogenic detrusor overactivity who completed 4 years of treatment","volume":"196","author":"Rovner","year":"2016","journal-title":"J. Urol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/nau.22293","article-title":"Treatment satisfaction and improvement in health-related quality of life with onabotulinumtoxina in patients with urinary incontinence due to neurogenic detrusor overactivity","volume":"32","author":"Sussman","year":"2013","journal-title":"Neurourol. Urodyn."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"275","DOI":"10.5213\/inj.1836118.059","article-title":"Efficacy and safety of onabotulinumtoxina in patients with neurogenic detrusor overactivity caused by spinal cord injury: A systematic review and meta-analysis","volume":"22","author":"Li","year":"2018","journal-title":"Int. Neurourol. J."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1002\/nau.23354","article-title":"Is repeat Botulinum Toxin A injection valuable for neurogenic detrusor overactivity-A systematic review and meta-analysis","volume":"37","author":"Ni","year":"2018","journal-title":"Neurourol. Urodyn."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1002\/nau.22934","article-title":"Efficacy and safety of onabotulinumtoxina therapy are sustained over 4 years of treatment in patients with neurogenic detrusor overactivity: Final results of a long-term extension study","volume":"36","author":"Kennelly","year":"2017","journal-title":"Neurourol. Urodyn."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/j.1464-410X.2011.010362.x","article-title":"Effects of intravesical onabotulinumtoxina on bladder dysfunction and autonomic dysreflexia after spinal cord injury: Role of nerve growth factor","volume":"109","author":"Elkelini","year":"2012","journal-title":"Br. J. Urol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/sc.2012.180","article-title":"Detrusor botulinum toxin A injection significantly decreased urinary tract infection in patients with traumatic spinal cord injury","volume":"51","author":"Jia","year":"2013","journal-title":"Spinal Cord"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.juro.2018.10.012","article-title":"Long-term discontinuation of botulinum toxin a intradetrusor injections for neurogenic detrusor overactivity: A multicenter study","volume":"201","author":"Baron","year":"2018","journal-title":"J. Urol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1111\/ijcp.12152","article-title":"Therapeutic outcome and quality of life between urethral and detrusor botulinum toxin treatment for patients with spinal cord lesions and detrusor sphincter dyssynergia","volume":"67","author":"Kuo","year":"2013","journal-title":"Int. J. Clin. Pract."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.eururo.2016.03.052","article-title":"More than 15 years of experience with intradetrusor onabotulinumtoxina injections for treating refractory neurogenic detrusor overactivity: Lessons to be learned","volume":"70","author":"Leitner","year":"2016","journal-title":"Eur. Urol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/sc.2010.179","article-title":"Therapeutic effects of detrusor botulinum toxin A injection on neurogenic detrusor overactivity in patients with different levels of spinal cord injury and types of detrusor sphincter dyssynergia","volume":"49","author":"Chen","year":"2011","journal-title":"Spinal Cord"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/s12325-013-0054-z","article-title":"onabotulinumtoxina is effective in patients with urinary incontinence due to neurogenic detrusor overactivity [corrected] regardless of concomitant anticholinergic use or neurologic etiology","volume":"30","author":"Ginsberg","year":"2013","journal-title":"Adv. Ther."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/s41393-019-0411-0","article-title":"Long term continuation with repeated Botulinum toxin A injections in people with neurogenic detrusor overactivity after spinal cord injury","volume":"58","author":"Hebert","year":"2020","journal-title":"Spinal Cord"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.jfma.2013.10.009","article-title":"Therapeutic outcome and patient adherence to repeated onabotulinumtoxina detrusor injections in chronic spinal cord-injured patients and neurogenic detrusor overactivity","volume":"114","author":"Chen","year":"2015","journal-title":"J. Formos. Med. Assoc."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1111\/bju.13976","article-title":"Intradetrusor onabotulinumtoxina injections for refractory neurogenic detrusor overactivity incontinence: Do we need urodynamic investigation for outcome assessment?","volume":"120","author":"Koschorke","year":"2017","journal-title":"BJU Int."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1590\/s1677-5538.ibju.2016.0584","article-title":"Long-term response of different Botulinum toxins in refractory neurogenic detrusor overactivity due to spinal cord injury","volume":"43","author":"Lombardi","year":"2017","journal-title":"Int. Braz J. Urol"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1002\/nau.23339","article-title":"A real-world experience with augmentation enterocystoplasty-High patient satisfaction with high complication rates","volume":"37","author":"Wu","year":"2018","journal-title":"Neurourol. Urodyn."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1038\/sc.2016.49","article-title":"Botulinum toxin therapy for neurogenic detrusor hyperactivity versus augmentation enterocystoplasty: Impact on the quality of life of patients with SCI","volume":"54","author":"Anquetil","year":"2016","journal-title":"Spinal Cord"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1007\/s11255-013-0625-6","article-title":"Complication rate of neurogenic lower urinary tract dysfunction after spinal cord injury in Taiwan","volume":"46","author":"Lai","year":"2014","journal-title":"Int. Urol. Nephrol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/nau.22757","article-title":"Patient-reported goal achievement following onabotulinumtoxinA treatment in patients with neurogenic detrusor overactivity","volume":"35","author":"Rovner","year":"2016","journal-title":"Neurourol. Urodyn."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.euf.2018.02.009","article-title":"Surgical Management of Anatomic Bladder Outlet Obstruction in Males with Neurogenic Bladder Dysfunction: A Systematic Review","volume":"5","author":"Noordhoff","year":"2018","journal-title":"Eur. Urol. Focus"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1089\/neu.2015.4278","article-title":"Reduction in bladder-related autonomic dysreflexia after onabotulinumtoxina tratment in spinal cord injury","volume":"33","author":"Fougere","year":"2016","journal-title":"J. Neurotrauma"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1097\/JU.0000000000002239","article-title":"The AUA\/SUFU Guideline on Adult Neurogenic Lower Urinary Tract Dysfunction: Treatment and Follow-up","volume":"206","author":"Ginsberg","year":"2021","journal-title":"J. Urol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.tcmj.2013.09.010","article-title":"Bladder management and urological complications in patients with chronic spinal cord injuries in Taiwan","volume":"26","author":"Chen","year":"2014","journal-title":"Tzu Chi Med. J."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/nau.10052","article-title":"Standardisation Sub-Committee of the International Continence Society. The standardisation of terminology of lower urinary tract function: Report from the Standardisation Sub-Committee of the International Continence Society","volume":"21","author":"Abrams","year":"2002","journal-title":"Neurourol. Urodyn."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/nau.22395","article-title":"The Therapeutic Effects of Repeated Detrusor Injections Between 200 or 300 Units of OnabotulinumtoxinA in Chronic Spinal Cord Injured Patients","volume":"33","author":"Chen","year":"2014","journal-title":"Neurourol. Urodyn."}],"container-title":["Toxins"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6651\/14\/1\/35\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T14:12:34Z","timestamp":1760364754000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6651\/14\/1\/35"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,3]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,1]]}},"alternative-id":["toxins14010035"],"URL":"https:\/\/doi.org\/10.3390\/toxins14010035","relation":{},"ISSN":["2072-6651"],"issn-type":[{"value":"2072-6651","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,3]]}}}